Overview
Brought to you by YData
Dataset statistics
| Number of variables | 27 |
|---|---|
| Number of observations | 22 |
| Missing cells | 66 |
| Missing cells (%) | 11.1% |
| Duplicate rows | 0 |
| Duplicate rows (%) | 0.0% |
| Total size in memory | 4.8 KiB |
| Average record size in memory | 222.0 B |
Variable types
| Numeric | 3 |
|---|---|
| Categorical | 20 |
| DateTime | 1 |
| Text | 2 |
| Boolean | 1 |
Able to ViablyPassage in nude mice is highly overall correlated with Age atDiagnosis and 15 other fields | High correlation |
Age atDiagnosis is highly overall correlated with Able to ViablyPassage in nude mice and 16 other fields | High correlation |
Age atSampling is highly overall correlated with Able to ViablyPassage in nude mice and 16 other fields | High correlation |
BiologicalSex is highly overall correlated with Age atDiagnosis and 11 other fields | High correlation |
BiopsySite is highly overall correlated with Able to ViablyPassage in nude mice and 20 other fields | High correlation |
CollectionDate is highly overall correlated with Able to ViablyPassage in nude mice and 20 other fields | High correlation |
Date ofDiagnosis is highly overall correlated with Able to ViablyPassage in nude mice and 20 other fields | High correlation |
Grade StageInformation is highly overall correlated with Able to ViablyPassage in nude mice and 14 other fields | High correlation |
Has KnownMetastaticDisease is highly overall correlated with Able to ViablyPassage in nude mice and 10 other fields | High correlation |
Has Smoked100 Cigarettes is highly overall correlated with Age atDiagnosis and 13 other fields | High correlation |
Human PathogenTesting Summary is highly overall correlated with Age atDiagnosis and 13 other fields | High correlation |
MSI Status is highly overall correlated with Able to ViablyPassage in nude mice and 13 other fields | High correlation |
ModelNotes is highly overall correlated with Able to ViablyPassage in nude mice and 20 other fields | High correlation |
Molecular andIHC Data is highly overall correlated with Able to ViablyPassage in nude mice and 21 other fields | High correlation |
Occupation is highly overall correlated with Able to ViablyPassage in nude mice and 20 other fields | High correlation |
PDX GrowthCurve Avail is highly overall correlated with Able to ViablyPassage in nude mice and 13 other fields | High correlation |
Patient ID is highly overall correlated with Able to ViablyPassage in nude mice and 18 other fields | High correlation |
PatientNotes is highly overall correlated with Able to ViablyPassage in nude mice and 20 other fields | High correlation |
ProvidedTissue Origin is highly overall correlated with BiopsySite and 10 other fields | High correlation |
Self-ReportedEthnicity is highly overall correlated with Age atDiagnosis and 13 other fields | High correlation |
Self-ReportedRace is highly overall correlated with Able to ViablyPassage in nude mice and 13 other fields | High correlation |
Specimen ID is highly overall correlated with Able to ViablyPassage in nude mice and 20 other fields | High correlation |
StandardizedRegimen is highly overall correlated with BiologicalSex and 3 other fields | High correlation |
Timing is highly overall correlated with StandardizedRegimen | High correlation |
ProvidedTissue Origin is highly imbalanced (56.1%) | Imbalance |
Date RegimenStarted has 11 (50.0%) missing values | Missing |
Best Response has 15 (68.2%) missing values | Missing |
AdditionalMedicalHistory has 8 (36.4%) missing values | Missing |
Molecular andIHC Data has 11 (50.0%) missing values | Missing |
Occupation has 3 (13.6%) missing values | Missing |
PatientNotes has 7 (31.8%) missing values | Missing |
ModelNotes has 11 (50.0%) missing values | Missing |
Date ofDiagnosis is uniformly distributed | Uniform |
Occupation is uniformly distributed | Uniform |
Specimen ID is uniformly distributed | Uniform |
CollectionDate is uniformly distributed | Uniform |
Reproduction
| Analysis started | 2025-07-15 01:49:53.056723 |
|---|---|
| Analysis finished | 2025-07-15 01:49:57.868900 |
| Duration | 4.81 seconds |
| Software version | ydata-profiling vv4.16.1 |
| Download configuration | config.json |
Variables
Patient ID
Real number (ℝ)
High correlation 
| Distinct | 10 |
|---|---|
| Distinct (%) | 45.5% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Infinite | 0 |
| Infinite (%) | 0.0% |
| Mean | 599045.59 |
| Minimum | 111316 |
|---|---|
| Maximum | 949853 |
| Zeros | 0 |
| Zeros (%) | 0.0% |
| Negative | 0 |
| Negative (%) | 0.0% |
| Memory size | 308.0 B |
Quantile statistics
| Minimum | 111316 |
|---|---|
| 5-th percentile | 118081.8 |
| Q1 | 376338.5 |
| median | 636974 |
| Q3 | 814656 |
| 95-th percentile | 947329.1 |
| Maximum | 949853 |
| Range | 838537 |
| Interquartile range (IQR) | 438317.5 |
Descriptive statistics
| Standard deviation | 269572.53 |
|---|---|
| Coefficient of variation (CV) | 0.45000336 |
| Kurtosis | -1.0015044 |
| Mean | 599045.59 |
| Median Absolute Deviation (MAD) | 207207 |
| Skewness | -0.47649441 |
| Sum | 13179003 |
| Variance | 7.2669347 × 1010 |
| Monotonicity | Increasing |
| Value | Count | Frequency (%) |
| 738633 | 3 | |
| 814656 | 3 | |
| 246632 | 2 | |
| 111316 | 2 | |
| 358529 | 2 | |
| 429767 | 2 | |
| 636974 | 2 | |
| 627122 | 2 | |
| 899375 | 2 | |
| 949853 | 2 |
| Value | Count | Frequency (%) |
| 111316 | 2 | |
| 246632 | 2 | |
| 358529 | 2 | |
| 429767 | 2 | |
| 627122 | 2 | |
| 636974 | 2 | |
| 738633 | 3 | |
| 814656 | 3 | |
| 899375 | 2 | |
| 949853 | 2 |
| Value | Count | Frequency (%) |
| 949853 | 2 | |
| 899375 | 2 | |
| 814656 | 3 | |
| 738633 | 3 | |
| 636974 | 2 | |
| 627122 | 2 | |
| 429767 | 2 | |
| 358529 | 2 | |
| 246632 | 2 | |
| 111316 | 2 |
Timing
Categorical
High correlation 
| Distinct | 2 |
|---|---|
| Distinct (%) | 9.1% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| Prior | |
|---|---|
| Current |
Length
| Max length | 7 |
|---|---|
| Median length | 5 |
| Mean length | 5.9090909 |
| Min length | 5 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | Current |
|---|---|
| 2nd row | Prior |
| 3rd row | Prior |
| 4th row | Current |
| 5th row | Prior |
Common Values
| Value | Count | Frequency (%) |
| Prior | 12 | |
| Current | 10 |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| prior | 12 | |
| current | 10 |
Most occurring characters
| Value | Count | Frequency (%) |
| r | 44 | |
| P | 12 | 9.2% |
| i | 12 | 9.2% |
| o | 12 | 9.2% |
| C | 10 | 7.7% |
| u | 10 | 7.7% |
| e | 10 | 7.7% |
| n | 10 | 7.7% |
| t | 10 | 7.7% |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 130 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| r | 44 | |
| P | 12 | 9.2% |
| i | 12 | 9.2% |
| o | 12 | 9.2% |
| C | 10 | 7.7% |
| u | 10 | 7.7% |
| e | 10 | 7.7% |
| n | 10 | 7.7% |
| t | 10 | 7.7% |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 130 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| r | 44 | |
| P | 12 | 9.2% |
| i | 12 | 9.2% |
| o | 12 | 9.2% |
| C | 10 | 7.7% |
| u | 10 | 7.7% |
| e | 10 | 7.7% |
| n | 10 | 7.7% |
| t | 10 | 7.7% |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 130 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| r | 44 | |
| P | 12 | 9.2% |
| i | 12 | 9.2% |
| o | 12 | 9.2% |
| C | 10 | 7.7% |
| u | 10 | 7.7% |
| e | 10 | 7.7% |
| n | 10 | 7.7% |
| t | 10 | 7.7% |
Missing 
| Distinct | 11 |
|---|---|
| Distinct (%) | 100.0% |
| Missing | 11 |
| Missing (%) | 50.0% |
| Memory size | 308.0 B |
| Minimum | 2007-05-01 00:00:00 |
|---|---|
| Maximum | 2021-08-01 00:00:00 |
| Invalid dates | 0 |
| Invalid dates (%) | 0.0% |
StandardizedRegimen
Categorical
High correlation 
| Distinct | 6 |
|---|---|
| Distinct (%) | 27.3% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| Imatinib Mesylate | |
|---|---|
| Treatment naive | |
| No Current Therapy | |
| Ripretinib | |
| Sunitinib Malate |
Length
| Max length | 18 |
|---|---|
| Median length | 17 |
| Mean length | 15.954545 |
| Min length | 9 |
Unique
| Unique | 3 ? |
|---|---|
| Unique (%) | 13.6% |
Sample
| 1st row | Ripretinib |
|---|---|
| 2nd row | Imatinib Mesylate |
| 3rd row | Treatment naive |
| 4th row | Treatment naive |
| 5th row | Imatinib Mesylate |
Common Values
| Value | Count | Frequency (%) |
| Imatinib Mesylate | 8 | |
| Treatment naive | 6 | |
| No Current Therapy | 5 | |
| Ripretinib | 1 | 4.5% |
| Sunitinib Malate | 1 | 4.5% |
| Radiation | 1 | 4.5% |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| imatinib | 8 | |
| mesylate | 8 | |
| treatment | 6 | |
| naive | 6 | |
| no | 5 | |
| current | 5 | |
| therapy | 5 | |
| ripretinib | 1 | 2.1% |
| sunitinib | 1 | 2.1% |
| malate | 1 | 2.1% |
Most occurring characters
| Value | Count | Frequency (%) |
| e | 46 | |
| t | 37 | |
| a | 37 | |
| i | 30 | 8.5% |
| n | 29 | 8.3% |
| 25 | 7.1% | |
| r | 22 | 6.3% |
| m | 14 | 4.0% |
| y | 13 | 3.7% |
| T | 11 | 3.1% |
| Other values (15) | 87 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 351 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| e | 46 | |
| t | 37 | |
| a | 37 | |
| i | 30 | 8.5% |
| n | 29 | 8.3% |
| 25 | 7.1% | |
| r | 22 | 6.3% |
| m | 14 | 4.0% |
| y | 13 | 3.7% |
| T | 11 | 3.1% |
| Other values (15) | 87 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 351 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| e | 46 | |
| t | 37 | |
| a | 37 | |
| i | 30 | 8.5% |
| n | 29 | 8.3% |
| 25 | 7.1% | |
| r | 22 | 6.3% |
| m | 14 | 4.0% |
| y | 13 | 3.7% |
| T | 11 | 3.1% |
| Other values (15) | 87 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 351 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| e | 46 | |
| t | 37 | |
| a | 37 | |
| i | 30 | 8.5% |
| n | 29 | 8.3% |
| 25 | 7.1% | |
| r | 22 | 6.3% |
| m | 14 | 4.0% |
| y | 13 | 3.7% |
| T | 11 | 3.1% |
| Other values (15) | 87 |
Best Response
Text
Missing 
| Distinct | 5 |
|---|---|
| Distinct (%) | 71.4% |
| Missing | 15 |
| Missing (%) | 68.2% |
| Memory size | 308.0 B |
Length
| Max length | 14 |
|---|---|
| Median length | 13 |
| Mean length | 8 |
| Min length | 2 |
Unique
| Unique | 3 ? |
|---|---|
| Unique (%) | 42.9% |
Sample
| 1st row | PR |
|---|---|
| 2nd row | Stable Disease |
| 3rd row | Stable Disease |
| 4th row | <Unknown> |
| 5th row | Non-evaluable |
| Value | Count | Frequency (%) |
| pr | 2 | |
| stable | 2 | |
| disease | 2 | |
| unknown | 1 | |
| non-evaluable | 1 | |
| cr | 1 |
Most occurring characters
| Value | Count | Frequency (%) |
| e | 8 | |
| a | 6 | 10.7% |
| l | 4 | 7.1% |
| s | 4 | 7.1% |
| n | 4 | 7.1% |
| R | 3 | 5.4% |
| b | 3 | 5.4% |
| t | 2 | 3.6% |
| S | 2 | 3.6% |
| P | 2 | 3.6% |
| Other values (14) | 18 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 56 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| e | 8 | |
| a | 6 | 10.7% |
| l | 4 | 7.1% |
| s | 4 | 7.1% |
| n | 4 | 7.1% |
| R | 3 | 5.4% |
| b | 3 | 5.4% |
| t | 2 | 3.6% |
| S | 2 | 3.6% |
| P | 2 | 3.6% |
| Other values (14) | 18 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 56 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| e | 8 | |
| a | 6 | 10.7% |
| l | 4 | 7.1% |
| s | 4 | 7.1% |
| n | 4 | 7.1% |
| R | 3 | 5.4% |
| b | 3 | 5.4% |
| t | 2 | 3.6% |
| S | 2 | 3.6% |
| P | 2 | 3.6% |
| Other values (14) | 18 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 56 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| e | 8 | |
| a | 6 | 10.7% |
| l | 4 | 7.1% |
| s | 4 | 7.1% |
| n | 4 | 7.1% |
| R | 3 | 5.4% |
| b | 3 | 5.4% |
| t | 2 | 3.6% |
| S | 2 | 3.6% |
| P | 2 | 3.6% |
| Other values (14) | 18 |
Self-ReportedRace
Categorical
High correlation 
| Distinct | 3 |
|---|---|
| Distinct (%) | 13.6% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| White | |
|---|---|
| Black or African American | |
| Not Provided |
Length
| Max length | 25 |
|---|---|
| Median length | 5 |
| Mean length | 10.5 |
| Min length | 5 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | White |
|---|---|
| 2nd row | White |
| 3rd row | White |
| 4th row | White |
| 5th row | White |
Common Values
| Value | Count | Frequency (%) |
| White | 14 | |
| Black or African American | 5 | 22.7% |
| Not Provided | 3 | 13.6% |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| white | 14 | |
| black | 5 | 12.5% |
| or | 5 | 12.5% |
| african | 5 | 12.5% |
| american | 5 | 12.5% |
| not | 3 | 7.5% |
| provided | 3 | 7.5% |
Most occurring characters
| Value | Count | Frequency (%) |
| i | 27 | |
| e | 22 | 9.5% |
| r | 18 | 7.8% |
| 18 | 7.8% | |
| t | 17 | 7.4% |
| c | 15 | 6.5% |
| a | 15 | 6.5% |
| h | 14 | 6.1% |
| W | 14 | 6.1% |
| o | 11 | 4.8% |
| Other values (11) | 60 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 231 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| i | 27 | |
| e | 22 | 9.5% |
| r | 18 | 7.8% |
| 18 | 7.8% | |
| t | 17 | 7.4% |
| c | 15 | 6.5% |
| a | 15 | 6.5% |
| h | 14 | 6.1% |
| W | 14 | 6.1% |
| o | 11 | 4.8% |
| Other values (11) | 60 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 231 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| i | 27 | |
| e | 22 | 9.5% |
| r | 18 | 7.8% |
| 18 | 7.8% | |
| t | 17 | 7.4% |
| c | 15 | 6.5% |
| a | 15 | 6.5% |
| h | 14 | 6.1% |
| W | 14 | 6.1% |
| o | 11 | 4.8% |
| Other values (11) | 60 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 231 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| i | 27 | |
| e | 22 | 9.5% |
| r | 18 | 7.8% |
| 18 | 7.8% | |
| t | 17 | 7.4% |
| c | 15 | 6.5% |
| a | 15 | 6.5% |
| h | 14 | 6.1% |
| W | 14 | 6.1% |
| o | 11 | 4.8% |
| Other values (11) | 60 |
Self-ReportedEthnicity
Categorical
High correlation 
| Distinct | 2 |
|---|---|
| Distinct (%) | 9.1% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| Not Hispanic or Latino | |
|---|---|
| Not Provided |
Length
| Max length | 22 |
|---|---|
| Median length | 22 |
| Mean length | 20.636364 |
| Min length | 12 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | Not Hispanic or Latino |
|---|---|
| 2nd row | Not Hispanic or Latino |
| 3rd row | Not Hispanic or Latino |
| 4th row | Not Hispanic or Latino |
| 5th row | Not Hispanic or Latino |
Common Values
| Value | Count | Frequency (%) |
| Not Hispanic or Latino | 19 | |
| Not Provided | 3 | 13.6% |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| not | 22 | |
| hispanic | 19 | |
| or | 19 | |
| latino | 19 | |
| provided | 3 | 3.7% |
Most occurring characters
| Value | Count | Frequency (%) |
| o | 63 | |
| i | 60 | |
| 60 | ||
| t | 41 | |
| a | 38 | |
| n | 38 | |
| N | 22 | 4.8% |
| r | 22 | 4.8% |
| H | 19 | 4.2% |
| p | 19 | 4.2% |
| Other values (7) | 72 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 454 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| o | 63 | |
| i | 60 | |
| 60 | ||
| t | 41 | |
| a | 38 | |
| n | 38 | |
| N | 22 | 4.8% |
| r | 22 | 4.8% |
| H | 19 | 4.2% |
| p | 19 | 4.2% |
| Other values (7) | 72 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 454 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| o | 63 | |
| i | 60 | |
| 60 | ||
| t | 41 | |
| a | 38 | |
| n | 38 | |
| N | 22 | 4.8% |
| r | 22 | 4.8% |
| H | 19 | 4.2% |
| p | 19 | 4.2% |
| Other values (7) | 72 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 454 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| o | 63 | |
| i | 60 | |
| 60 | ||
| t | 41 | |
| a | 38 | |
| n | 38 | |
| N | 22 | 4.8% |
| r | 22 | 4.8% |
| H | 19 | 4.2% |
| p | 19 | 4.2% |
| Other values (7) | 72 |
BiologicalSex
Categorical
High correlation 
| Distinct | 2 |
|---|---|
| Distinct (%) | 9.1% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| Male | |
|---|---|
| Female |
Length
| Max length | 6 |
|---|---|
| Median length | 4 |
| Mean length | 4.9090909 |
| Min length | 4 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | Male |
|---|---|
| 2nd row | Male |
| 3rd row | Male |
| 4th row | Male |
| 5th row | Female |
Common Values
| Value | Count | Frequency (%) |
| Male | 12 | |
| Female | 10 |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| male | 12 | |
| female | 10 |
Most occurring characters
| Value | Count | Frequency (%) |
| e | 32 | |
| a | 22 | |
| l | 22 | |
| M | 12 | 11.1% |
| F | 10 | 9.3% |
| m | 10 | 9.3% |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 108 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| e | 32 | |
| a | 22 | |
| l | 22 | |
| M | 12 | 11.1% |
| F | 10 | 9.3% |
| m | 10 | 9.3% |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 108 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| e | 32 | |
| a | 22 | |
| l | 22 | |
| M | 12 | 11.1% |
| F | 10 | 9.3% |
| m | 10 | 9.3% |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 108 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| e | 32 | |
| a | 22 | |
| l | 22 | |
| M | 12 | 11.1% |
| F | 10 | 9.3% |
| m | 10 | 9.3% |
Age atDiagnosis
Real number (ℝ)
High correlation 
| Distinct | 9 |
|---|---|
| Distinct (%) | 40.9% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Infinite | 0 |
| Infinite (%) | 0.0% |
| Mean | 50.272727 |
| Minimum | 31 |
|---|---|
| Maximum | 80 |
| Zeros | 0 |
| Zeros (%) | 0.0% |
| Negative | 0 |
| Negative (%) | 0.0% |
| Memory size | 308.0 B |
Quantile statistics
| Minimum | 31 |
|---|---|
| 5-th percentile | 31 |
| Q1 | 39 |
| median | 52 |
| Q3 | 57.75 |
| 95-th percentile | 79.3 |
| Maximum | 80 |
| Range | 49 |
| Interquartile range (IQR) | 18.75 |
Descriptive statistics
| Standard deviation | 14.836191 |
|---|---|
| Coefficient of variation (CV) | 0.2951141 |
| Kurtosis | -0.49114955 |
| Mean | 50.272727 |
| Median Absolute Deviation (MAD) | 13 |
| Skewness | 0.44699848 |
| Sum | 1106 |
| Variance | 220.11255 |
| Monotonicity | Not monotonic |
| Value | Count | Frequency (%) |
| 39 | 4 | |
| 57 | 3 | |
| 31 | 3 | |
| 58 | 2 | |
| 35 | 2 | |
| 53 | 2 | |
| 51 | 2 | |
| 66 | 2 | |
| 80 | 2 |
| Value | Count | Frequency (%) |
| 31 | 3 | |
| 35 | 2 | |
| 39 | 4 | |
| 51 | 2 | |
| 53 | 2 | |
| 57 | 3 | |
| 58 | 2 | |
| 66 | 2 | |
| 80 | 2 |
| Value | Count | Frequency (%) |
| 80 | 2 | |
| 66 | 2 | |
| 58 | 2 | |
| 57 | 3 | |
| 53 | 2 | |
| 51 | 2 | |
| 39 | 4 | |
| 35 | 2 | |
| 31 | 3 |
Missing 
| Distinct | 7 |
|---|---|
| Distinct (%) | 50.0% |
| Missing | 8 |
| Missing (%) | 36.4% |
| Memory size | 308.0 B |
Length
| Max length | 155 |
|---|---|
| Median length | 86 |
| Mean length | 85.285714 |
| Min length | 33 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | Final Pathology: Dx confirmed; mitotic rate is 47/30 HPF; treatment effect present w/central necrosis. |
|---|---|
| 2nd row | Final Pathology: Dx confirmed; mitotic rate is 47/30 HPF; treatment effect present w/central necrosis. |
| 3rd row | Concurrent malignancy - SDHB gene mutation associated paraganglioma |
| 4th row | Concurrent malignancy - SDHB gene mutation associated paraganglioma |
| 5th row | Final Pathology: Dx confirmed with treatment effect present; 50% viable tumor remains |
| Value | Count | Frequency (%) |
| final | 6 | 3.9% |
| pathology | 6 | 3.9% |
| dx | 6 | 3.9% |
| confirmed | 6 | 3.9% |
| mitotic | 4 | 2.6% |
| treatment | 4 | 2.6% |
| effect | 4 | 2.6% |
| malignancy | 4 | 2.6% |
| 4 | 2.6% | |
| tumor | 4 | 2.6% |
| Other values (49) | 104 |
Most occurring characters
| Value | Count | Frequency (%) |
| 144 | 12.1% | |
| e | 98 | 8.2% |
| t | 96 | 8.0% |
| a | 92 | 7.7% |
| r | 78 | 6.5% |
| i | 76 | 6.4% |
| n | 74 | 6.2% |
| o | 74 | 6.2% |
| l | 52 | 4.4% |
| c | 50 | 4.2% |
| Other values (39) | 360 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 1194 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 144 | 12.1% | |
| e | 98 | 8.2% |
| t | 96 | 8.0% |
| a | 92 | 7.7% |
| r | 78 | 6.5% |
| i | 76 | 6.4% |
| n | 74 | 6.2% |
| o | 74 | 6.2% |
| l | 52 | 4.4% |
| c | 50 | 4.2% |
| Other values (39) | 360 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 1194 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 144 | 12.1% | |
| e | 98 | 8.2% |
| t | 96 | 8.0% |
| a | 92 | 7.7% |
| r | 78 | 6.5% |
| i | 76 | 6.4% |
| n | 74 | 6.2% |
| o | 74 | 6.2% |
| l | 52 | 4.4% |
| c | 50 | 4.2% |
| Other values (39) | 360 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 1194 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 144 | 12.1% | |
| e | 98 | 8.2% |
| t | 96 | 8.0% |
| a | 92 | 7.7% |
| r | 78 | 6.5% |
| i | 76 | 6.4% |
| n | 74 | 6.2% |
| o | 74 | 6.2% |
| l | 52 | 4.4% |
| c | 50 | 4.2% |
| Other values (39) | 360 |
Date ofDiagnosis
Categorical
High correlation  Uniform 
| Distinct | 10 |
|---|---|
| Distinct (%) | 45.5% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| 03/2014 | |
|---|---|
| 07/2009 | |
| 11/2017 | |
| 07/2020 | |
| 12/2017 | |
| Other values (5) |
Length
| Max length | 7 |
|---|---|
| Median length | 7 |
| Mean length | 7 |
| Min length | 7 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | 07/2020 |
|---|---|
| 2nd row | 07/2020 |
| 3rd row | 11/2017 |
| 4th row | 11/2017 |
| 5th row | 12/2017 |
Common Values
| Value | Count | Frequency (%) |
| 03/2014 | 3 | |
| 07/2009 | 3 | |
| 11/2017 | 2 | |
| 07/2020 | 2 | |
| 12/2017 | 2 | |
| 01/2007 | 2 | |
| 10/2013 | 2 | |
| 02/2017 | 2 | |
| 06/2017 | 2 | |
| 10/2015 | 2 |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| 03/2014 | 3 | |
| 07/2009 | 3 | |
| 11/2017 | 2 | |
| 07/2020 | 2 | |
| 12/2017 | 2 | |
| 01/2007 | 2 | |
| 10/2013 | 2 | |
| 02/2017 | 2 | |
| 06/2017 | 2 | |
| 10/2015 | 2 |
Most occurring characters
| Value | Count | Frequency (%) |
| 0 | 47 | |
| 2 | 28 | |
| 1 | 27 | |
| / | 22 | |
| 7 | 15 | 9.7% |
| 3 | 5 | 3.2% |
| 4 | 3 | 1.9% |
| 9 | 3 | 1.9% |
| 6 | 2 | 1.3% |
| 5 | 2 | 1.3% |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 154 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 0 | 47 | |
| 2 | 28 | |
| 1 | 27 | |
| / | 22 | |
| 7 | 15 | 9.7% |
| 3 | 5 | 3.2% |
| 4 | 3 | 1.9% |
| 9 | 3 | 1.9% |
| 6 | 2 | 1.3% |
| 5 | 2 | 1.3% |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 154 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 0 | 47 | |
| 2 | 28 | |
| 1 | 27 | |
| / | 22 | |
| 7 | 15 | 9.7% |
| 3 | 5 | 3.2% |
| 4 | 3 | 1.9% |
| 9 | 3 | 1.9% |
| 6 | 2 | 1.3% |
| 5 | 2 | 1.3% |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 154 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 0 | 47 | |
| 2 | 28 | |
| 1 | 27 | |
| / | 22 | |
| 7 | 15 | 9.7% |
| 3 | 5 | 3.2% |
| 4 | 3 | 1.9% |
| 9 | 3 | 1.9% |
| 6 | 2 | 1.3% |
| 5 | 2 | 1.3% |
Grade StageInformation
Categorical
High correlation 
| Distinct | 5 |
|---|---|
| Distinct (%) | 22.7% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| None Provided | |
|---|---|
| Grade, TNM | |
| Grade, TNM (Clinical) | |
| Grade, TNM (Pathological) | |
| TNM (Pathological) |
Length
| Max length | 25 |
|---|---|
| Median length | 23 |
| Mean length | 14.590909 |
| Min length | 10 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | Grade, TNM (Clinical) |
|---|---|
| 2nd row | Grade, TNM (Clinical) |
| 3rd row | None Provided |
| 4th row | None Provided |
| 5th row | Grade, TNM (Pathological) |
Common Values
| Value | Count | Frequency (%) |
| None Provided | 11 | |
| Grade, TNM | 5 | |
| Grade, TNM (Clinical) | 2 | 9.1% |
| Grade, TNM (Pathological) | 2 | 9.1% |
| TNM (Pathological) | 2 | 9.1% |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| none | 11 | |
| provided | 11 | |
| tnm | 11 | |
| grade | 9 | |
| pathological | 4 | 8.3% |
| clinical | 2 | 4.2% |
Most occurring characters
| Value | Count | Frequency (%) |
| e | 31 | 9.7% |
| d | 31 | 9.7% |
| o | 30 | 9.3% |
| 26 | 8.1% | |
| N | 22 | 6.9% |
| r | 20 | 6.2% |
| i | 19 | 5.9% |
| a | 19 | 5.9% |
| P | 15 | 4.7% |
| n | 13 | 4.0% |
| Other values (13) | 95 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 321 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| e | 31 | 9.7% |
| d | 31 | 9.7% |
| o | 30 | 9.3% |
| 26 | 8.1% | |
| N | 22 | 6.9% |
| r | 20 | 6.2% |
| i | 19 | 5.9% |
| a | 19 | 5.9% |
| P | 15 | 4.7% |
| n | 13 | 4.0% |
| Other values (13) | 95 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 321 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| e | 31 | 9.7% |
| d | 31 | 9.7% |
| o | 30 | 9.3% |
| 26 | 8.1% | |
| N | 22 | 6.9% |
| r | 20 | 6.2% |
| i | 19 | 5.9% |
| a | 19 | 5.9% |
| P | 15 | 4.7% |
| n | 13 | 4.0% |
| Other values (13) | 95 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 321 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| e | 31 | 9.7% |
| d | 31 | 9.7% |
| o | 30 | 9.3% |
| 26 | 8.1% | |
| N | 22 | 6.9% |
| r | 20 | 6.2% |
| i | 19 | 5.9% |
| a | 19 | 5.9% |
| P | 15 | 4.7% |
| n | 13 | 4.0% |
| Other values (13) | 95 |
Has KnownMetastaticDisease
Categorical
High correlation 
| Distinct | 2 |
|---|---|
| Distinct (%) | 9.1% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| Not Reported | |
|---|---|
| Yes |
Length
| Max length | 12 |
|---|---|
| Median length | 12 |
| Mean length | 8.7272727 |
| Min length | 3 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | Yes |
|---|---|
| 2nd row | Yes |
| 3rd row | Not Reported |
| 4th row | Not Reported |
| 5th row | Not Reported |
Common Values
| Value | Count | Frequency (%) |
| Not Reported | 14 | |
| Yes | 8 |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| not | 14 | |
| reported | 14 | |
| yes | 8 |
Most occurring characters
| Value | Count | Frequency (%) |
| e | 36 | |
| t | 28 | |
| o | 28 | |
| N | 14 | 7.3% |
| 14 | 7.3% | |
| R | 14 | 7.3% |
| p | 14 | 7.3% |
| r | 14 | 7.3% |
| d | 14 | 7.3% |
| Y | 8 | 4.2% |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 192 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| e | 36 | |
| t | 28 | |
| o | 28 | |
| N | 14 | 7.3% |
| 14 | 7.3% | |
| R | 14 | 7.3% |
| p | 14 | 7.3% |
| r | 14 | 7.3% |
| d | 14 | 7.3% |
| Y | 8 | 4.2% |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 192 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| e | 36 | |
| t | 28 | |
| o | 28 | |
| N | 14 | 7.3% |
| 14 | 7.3% | |
| R | 14 | 7.3% |
| p | 14 | 7.3% |
| r | 14 | 7.3% |
| d | 14 | 7.3% |
| Y | 8 | 4.2% |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 192 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| e | 36 | |
| t | 28 | |
| o | 28 | |
| N | 14 | 7.3% |
| 14 | 7.3% | |
| R | 14 | 7.3% |
| p | 14 | 7.3% |
| r | 14 | 7.3% |
| d | 14 | 7.3% |
| Y | 8 | 4.2% |
Has Smoked100 Cigarettes
Categorical
High correlation 
| Distinct | 3 |
|---|---|
| Distinct (%) | 13.6% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| No | |
|---|---|
| Yes | |
| Not Provided |
Length
| Max length | 12 |
|---|---|
| Median length | 7.5 |
| Mean length | 3.7272727 |
| Min length | 2 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | No |
|---|---|
| 2nd row | No |
| 3rd row | No |
| 4th row | No |
| 5th row | Yes |
Common Values
| Value | Count | Frequency (%) |
| No | 11 | |
| Yes | 8 | |
| Not Provided | 3 | 13.6% |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| no | 11 | |
| yes | 8 | |
| not | 3 | 12.0% |
| provided | 3 | 12.0% |
Most occurring characters
| Value | Count | Frequency (%) |
| o | 17 | |
| N | 14 | |
| e | 11 | |
| Y | 8 | |
| s | 8 | |
| d | 6 | 7.3% |
| 3 | 3.7% | |
| t | 3 | 3.7% |
| P | 3 | 3.7% |
| r | 3 | 3.7% |
| Other values (2) | 6 | 7.3% |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 82 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| o | 17 | |
| N | 14 | |
| e | 11 | |
| Y | 8 | |
| s | 8 | |
| d | 6 | 7.3% |
| 3 | 3.7% | |
| t | 3 | 3.7% |
| P | 3 | 3.7% |
| r | 3 | 3.7% |
| Other values (2) | 6 | 7.3% |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 82 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| o | 17 | |
| N | 14 | |
| e | 11 | |
| Y | 8 | |
| s | 8 | |
| d | 6 | 7.3% |
| 3 | 3.7% | |
| t | 3 | 3.7% |
| P | 3 | 3.7% |
| r | 3 | 3.7% |
| Other values (2) | 6 | 7.3% |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 82 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| o | 17 | |
| N | 14 | |
| e | 11 | |
| Y | 8 | |
| s | 8 | |
| d | 6 | 7.3% |
| 3 | 3.7% | |
| t | 3 | 3.7% |
| P | 3 | 3.7% |
| r | 3 | 3.7% |
| Other values (2) | 6 | 7.3% |
Molecular andIHC Data
Categorical
High correlation  Missing 
| Distinct | 5 |
|---|---|
| Distinct (%) | 45.5% |
| Missing | 11 |
| Missing (%) | 50.0% |
| Memory size | 308.0 B |
| Biomarkers: c-KIT mutated, DOG1+ | |
|---|---|
| c.445C>T (p.Q149*) variant in the SDHB gene | |
| IHC: DOG1+, CD117+; S100-, CK AE1/AE3- | |
| IHC (from 10/2013 primary diagnosis): CKIT+, CD34+, BCL2+, CDX2 -, CK7 -, CK20 -, Melan-A -, S-100 -, Vimentin -. PDGFRA exon 12 &18 mutation negative. | |
| IHC: DOG1+, CD117+, and PDGFR+ consistent with a gastrointestinal stromal tumor (GIST). |
Length
| Max length | 152 |
|---|---|
| Median length | 43 |
| Mean length | 67.363636 |
| Min length | 33 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | IHC: DOG1+, CD117+; S100-, CK AE1/AE3- |
|---|---|
| 2nd row | IHC: DOG1+, CD117+; S100-, CK AE1/AE3- |
| 3rd row | c.445C>T (p.Q149*) variant in the SDHB gene |
| 4th row | c.445C>T (p.Q149*) variant in the SDHB gene |
| 5th row | IHC (from 10/2013 primary diagnosis): CKIT+, CD34+, BCL2+, CDX2 -, CK7 -, CK20 -, Melan-A -, S-100 -, Vimentin -. PDGFRA exon 12 &18 mutation negative. |
Common Values
| Value | Count | Frequency (%) |
| Biomarkers: c-KIT mutated, DOG1+ | 3 | 13.6% |
| c.445C>T (p.Q149*) variant in the SDHB gene | 2 | 9.1% |
| IHC: DOG1+, CD117+; S100-, CK AE1/AE3- | 2 | 9.1% |
| IHC (from 10/2013 primary diagnosis): CKIT+, CD34+, BCL2+, CDX2 -, CK7 -, CK20 -, Melan-A -, S-100 -, Vimentin -. PDGFRA exon 12 &18 mutation negative. | 2 | 9.1% |
| IHC: DOG1+, CD117+, and PDGFR+ consistent with a gastrointestinal stromal tumor (GIST). | 2 | 9.1% |
| (Missing) | 11 |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| 12 | 10.5% | |
| dog1 | 7 | 6.1% |
| ihc | 6 | 5.3% |
| cd117 | 4 | 3.5% |
| biomarkers | 3 | 2.6% |
| mutated | 3 | 2.6% |
| c-kit | 3 | 2.6% |
| p.q149 | 2 | 1.8% |
| c.445c>t | 2 | 1.8% |
| the | 2 | 1.8% |
| Other values (35) | 70 |
Most occurring characters
| Value | Count | Frequency (%) |
| 110 | 14.8% | |
| t | 34 | 4.6% |
| 1 | 31 | 4.2% |
| a | 30 | 4.0% |
| n | 30 | 4.0% |
| i | 29 | 3.9% |
| , | 27 | 3.6% |
| C | 26 | 3.5% |
| e | 26 | 3.5% |
| - | 23 | 3.1% |
| Other values (54) | 375 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 741 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 110 | 14.8% | |
| t | 34 | 4.6% |
| 1 | 31 | 4.2% |
| a | 30 | 4.0% |
| n | 30 | 4.0% |
| i | 29 | 3.9% |
| , | 27 | 3.6% |
| C | 26 | 3.5% |
| e | 26 | 3.5% |
| - | 23 | 3.1% |
| Other values (54) | 375 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 741 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 110 | 14.8% | |
| t | 34 | 4.6% |
| 1 | 31 | 4.2% |
| a | 30 | 4.0% |
| n | 30 | 4.0% |
| i | 29 | 3.9% |
| , | 27 | 3.6% |
| C | 26 | 3.5% |
| e | 26 | 3.5% |
| - | 23 | 3.1% |
| Other values (54) | 375 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 741 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 110 | 14.8% | |
| t | 34 | 4.6% |
| 1 | 31 | 4.2% |
| a | 30 | 4.0% |
| n | 30 | 4.0% |
| i | 29 | 3.9% |
| , | 27 | 3.6% |
| C | 26 | 3.5% |
| e | 26 | 3.5% |
| - | 23 | 3.1% |
| Other values (54) | 375 |
Occupation
Categorical
High correlation  Missing  Uniform 
| Distinct | 9 |
|---|---|
| Distinct (%) | 47.4% |
| Missing | 3 |
| Missing (%) | 13.6% |
| Memory size | 308.0 B |
| Not Provided | |
|---|---|
| insurance industry | |
| Engineer | |
| Department Manger | |
| Disabled | |
| Other values (4) |
Length
| Max length | 39 |
|---|---|
| Median length | 17 |
| Mean length | 15.947368 |
| Min length | 7 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | Engineer |
|---|---|
| 2nd row | Engineer |
| 3rd row | insurance industry |
| 4th row | insurance industry |
| 5th row | Department Manger |
Common Values
| Value | Count | Frequency (%) |
| Not Provided | 3 | |
| insurance industry | 2 | |
| Engineer | 2 | |
| Department Manger | 2 | |
| Disabled | 2 | |
| Unknown | 2 | |
| Park Service | 2 | |
| Retired; prior occupation not provided | 2 | |
| Plastics factory worker | 2 | |
| (Missing) | 3 |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| not | 5 | 12.5% |
| provided | 5 | 12.5% |
| insurance | 2 | 5.0% |
| industry | 2 | 5.0% |
| engineer | 2 | 5.0% |
| department | 2 | 5.0% |
| manger | 2 | 5.0% |
| disabled | 2 | 5.0% |
| unknown | 2 | 5.0% |
| park | 2 | 5.0% |
| Other values (7) | 14 |
Most occurring characters
| Value | Count | Frequency (%) |
| r | 31 | 10.2% |
| e | 29 | 9.6% |
| 26 | 8.6% | |
| n | 24 | 7.9% |
| i | 23 | 7.6% |
| o | 22 | 7.3% |
| t | 19 | 6.3% |
| a | 16 | 5.3% |
| d | 16 | 5.3% |
| c | 12 | 4.0% |
| Other values (21) | 85 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 303 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| r | 31 | 10.2% |
| e | 29 | 9.6% |
| 26 | 8.6% | |
| n | 24 | 7.9% |
| i | 23 | 7.6% |
| o | 22 | 7.3% |
| t | 19 | 6.3% |
| a | 16 | 5.3% |
| d | 16 | 5.3% |
| c | 12 | 4.0% |
| Other values (21) | 85 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 303 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| r | 31 | 10.2% |
| e | 29 | 9.6% |
| 26 | 8.6% | |
| n | 24 | 7.9% |
| i | 23 | 7.6% |
| o | 22 | 7.3% |
| t | 19 | 6.3% |
| a | 16 | 5.3% |
| d | 16 | 5.3% |
| c | 12 | 4.0% |
| Other values (21) | 85 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 303 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| r | 31 | 10.2% |
| e | 29 | 9.6% |
| 26 | 8.6% | |
| n | 24 | 7.9% |
| i | 23 | 7.6% |
| o | 22 | 7.3% |
| t | 19 | 6.3% |
| a | 16 | 5.3% |
| d | 16 | 5.3% |
| c | 12 | 4.0% |
| Other values (21) | 85 |
PatientNotes
Categorical
High correlation  Missing 
| Distinct | 7 |
|---|---|
| Distinct (%) | 46.7% |
| Missing | 7 |
| Missing (%) | 31.8% |
| Memory size | 308.0 B |
| Disease recurrence at distant site Tumor Grade/Stage: Grade 2, T2N0M1 | |
|---|---|
| Pt has concurrent malignancies - GIST and SDHB gene mutation associated paraganglioma | |
| Tumor Grade/Stage: cM0 (at diagnosis); high grade Location of known metastasis: liver, jejunum, ileum | |
| Tumor Stage/Grade: G1 - 1 low grade; pT3 pN0 pM not applicable | |
| Tumor Grade/Stage: High grade, T4NXM1 | |
| Other values (2) |
Length
| Max length | 102 |
|---|---|
| Median length | 62 |
| Mean length | 60.8 |
| Min length | 26 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | Tumor Grade/Stage: cM0 (at diagnosis); high grade Location of known metastasis: liver, jejunum, ileum |
|---|---|
| 2nd row | Tumor Grade/Stage: cM0 (at diagnosis); high grade Location of known metastasis: liver, jejunum, ileum |
| 3rd row | Pt has concurrent malignancies - GIST and SDHB gene mutation associated paraganglioma |
| 4th row | Pt has concurrent malignancies - GIST and SDHB gene mutation associated paraganglioma |
| 5th row | Tumor Stage/Grade: G1 - 1 low grade; pT3 pN0 pM not applicable |
Common Values
| Value | Count | Frequency (%) |
| Disease recurrence at distant site Tumor Grade/Stage: Grade 2, T2N0M1 | 3 | |
| Pt has concurrent malignancies - GIST and SDHB gene mutation associated paraganglioma | 2 | 9.1% |
| Tumor Grade/Stage: cM0 (at diagnosis); high grade Location of known metastasis: liver, jejunum, ileum | 2 | 9.1% |
| Tumor Stage/Grade: G1 - 1 low grade; pT3 pN0 pM not applicable | 2 | 9.1% |
| Tumor Grade/Stage: High grade, T4NXM1 | 2 | 9.1% |
| Tumor Grade/Stage: pT2NX | 2 | 9.1% |
| Location of know metastases: liver | 2 | 9.1% |
| (Missing) | 7 |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| tumor | 11 | 8.3% |
| grade/stage | 9 | 6.8% |
| grade | 9 | 6.8% |
| at | 5 | 3.8% |
| 4 | 3.0% | |
| high | 4 | 3.0% |
| location | 4 | 3.0% |
| of | 4 | 3.0% |
| liver | 4 | 3.0% |
| site | 3 | 2.3% |
| Other values (35) | 75 |
Most occurring characters
| Value | Count | Frequency (%) |
| 116 | 12.7% | |
| a | 82 | 9.0% |
| e | 75 | 8.2% |
| r | 50 | 5.5% |
| t | 49 | 5.4% |
| i | 41 | 4.5% |
| o | 41 | 4.5% |
| n | 38 | 4.2% |
| s | 36 | 3.9% |
| g | 31 | 3.4% |
| Other values (38) | 353 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 912 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 116 | 12.7% | |
| a | 82 | 9.0% |
| e | 75 | 8.2% |
| r | 50 | 5.5% |
| t | 49 | 5.4% |
| i | 41 | 4.5% |
| o | 41 | 4.5% |
| n | 38 | 4.2% |
| s | 36 | 3.9% |
| g | 31 | 3.4% |
| Other values (38) | 353 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 912 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 116 | 12.7% | |
| a | 82 | 9.0% |
| e | 75 | 8.2% |
| r | 50 | 5.5% |
| t | 49 | 5.4% |
| i | 41 | 4.5% |
| o | 41 | 4.5% |
| n | 38 | 4.2% |
| s | 36 | 3.9% |
| g | 31 | 3.4% |
| Other values (38) | 353 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 912 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 116 | 12.7% | |
| a | 82 | 9.0% |
| e | 75 | 8.2% |
| r | 50 | 5.5% |
| t | 49 | 5.4% |
| i | 41 | 4.5% |
| o | 41 | 4.5% |
| n | 38 | 4.2% |
| s | 36 | 3.9% |
| g | 31 | 3.4% |
| Other values (38) | 353 |
Specimen ID
Categorical
High correlation  Uniform 
| Distinct | 10 |
|---|---|
| Distinct (%) | 45.5% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| 008-R | |
|---|---|
| 196-R | |
| 235-R1 | |
| 319-R | |
| 109-R | |
| Other values (5) |
Length
| Max length | 6 |
|---|---|
| Median length | 5 |
| Mean length | 5.0909091 |
| Min length | 5 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | 319-R |
|---|---|
| 2nd row | 319-R |
| 3rd row | 235-R1 |
| 4th row | 235-R1 |
| 5th row | 109-R |
Common Values
| Value | Count | Frequency (%) |
| 008-R | 3 | |
| 196-R | 3 | |
| 235-R1 | 2 | |
| 319-R | 2 | |
| 109-R | 2 | |
| 202-R | 2 | |
| 082-R | 2 | |
| 101-R | 2 | |
| 194-R | 2 | |
| 013-R | 2 |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| 008-r | 3 | |
| 196-r | 3 | |
| 235-r1 | 2 | |
| 319-r | 2 | |
| 109-r | 2 | |
| 202-r | 2 | |
| 082-r | 2 | |
| 101-r | 2 | |
| 194-r | 2 | |
| 013-r | 2 |
Most occurring characters
| Value | Count | Frequency (%) |
| - | 22 | |
| R | 22 | |
| 1 | 17 | |
| 0 | 16 | |
| 9 | 9 | |
| 2 | 8 | 7.1% |
| 3 | 6 | 5.4% |
| 8 | 5 | 4.5% |
| 6 | 3 | 2.7% |
| 5 | 2 | 1.8% |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 112 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| - | 22 | |
| R | 22 | |
| 1 | 17 | |
| 0 | 16 | |
| 9 | 9 | |
| 2 | 8 | 7.1% |
| 3 | 6 | 5.4% |
| 8 | 5 | 4.5% |
| 6 | 3 | 2.7% |
| 5 | 2 | 1.8% |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 112 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| - | 22 | |
| R | 22 | |
| 1 | 17 | |
| 0 | 16 | |
| 9 | 9 | |
| 2 | 8 | 7.1% |
| 3 | 6 | 5.4% |
| 8 | 5 | 4.5% |
| 6 | 3 | 2.7% |
| 5 | 2 | 1.8% |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 112 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| - | 22 | |
| R | 22 | |
| 1 | 17 | |
| 0 | 16 | |
| 9 | 9 | |
| 2 | 8 | 7.1% |
| 3 | 6 | 5.4% |
| 8 | 5 | 4.5% |
| 6 | 3 | 2.7% |
| 5 | 2 | 1.8% |
BiopsySite
Categorical
High correlation 
| Distinct | 9 |
|---|---|
| Distinct (%) | 40.9% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| Stomach | |
|---|---|
| Stomach [distal] | |
| Stomach/Liver | |
| Liver [central] | |
| Gastric | |
| Other values (4) |
Length
| Max length | 16 |
|---|---|
| Median length | 14 |
| Mean length | 11.863636 |
| Min length | 7 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | Liver [central] |
|---|---|
| 2nd row | Liver [central] |
| 3rd row | Gastric |
| 4th row | Gastric |
| 5th row | Stomach |
Common Values
| Value | Count | Frequency (%) |
| Stomach | 4 | |
| Stomach [distal] | 3 | |
| Stomach/Liver | 3 | |
| Liver [central] | 2 | |
| Gastric | 2 | |
| Gastric Fundus | 2 | |
| Abdominal Mass | 2 | |
| abdominal mass | 2 | |
| Stomach | 2 |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| stomach | 9 | |
| abdominal | 4 | |
| mass | 4 | |
| gastric | 4 | |
| distal | 3 | 9.1% |
| stomach/liver | 3 | 9.1% |
| liver | 2 | 6.1% |
| central | 2 | 6.1% |
| fundus | 2 | 6.1% |
Most occurring characters
| Value | Count | Frequency (%) |
| a | 31 | 11.9% |
| t | 21 | 8.0% |
| c | 18 | 6.9% |
| m | 18 | 6.9% |
| s | 17 | 6.5% |
| o | 16 | 6.1% |
| i | 16 | 6.1% |
| 15 | 5.7% | |
| S | 12 | 4.6% |
| h | 12 | 4.6% |
| Other values (16) | 85 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 261 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| a | 31 | 11.9% |
| t | 21 | 8.0% |
| c | 18 | 6.9% |
| m | 18 | 6.9% |
| s | 17 | 6.5% |
| o | 16 | 6.1% |
| i | 16 | 6.1% |
| 15 | 5.7% | |
| S | 12 | 4.6% |
| h | 12 | 4.6% |
| Other values (16) | 85 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 261 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| a | 31 | 11.9% |
| t | 21 | 8.0% |
| c | 18 | 6.9% |
| m | 18 | 6.9% |
| s | 17 | 6.5% |
| o | 16 | 6.1% |
| i | 16 | 6.1% |
| 15 | 5.7% | |
| S | 12 | 4.6% |
| h | 12 | 4.6% |
| Other values (16) | 85 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 261 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| a | 31 | 11.9% |
| t | 21 | 8.0% |
| c | 18 | 6.9% |
| m | 18 | 6.9% |
| s | 17 | 6.5% |
| o | 16 | 6.1% |
| i | 16 | 6.1% |
| 15 | 5.7% | |
| S | 12 | 4.6% |
| h | 12 | 4.6% |
| Other values (16) | 85 |
PDX GrowthCurve Avail
Boolean
High correlation 
| Distinct | 2 |
|---|---|
| Distinct (%) | 9.1% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 154.0 B |
| True | |
|---|---|
| False |
| Value | Count | Frequency (%) |
| True | 16 | |
| False | 6 | 27.3% |
MSI Status
Categorical
High correlation 
| Distinct | 2 |
|---|---|
| Distinct (%) | 9.1% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| MSI-Stable | |
|---|---|
| Unknown |
Length
| Max length | 10 |
|---|---|
| Median length | 10 |
| Mean length | 9.1818182 |
| Min length | 7 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | MSI-Stable |
|---|---|
| 2nd row | MSI-Stable |
| 3rd row | Unknown |
| 4th row | Unknown |
| 5th row | Unknown |
Common Values
| Value | Count | Frequency (%) |
| MSI-Stable | 16 | |
| Unknown | 6 | 27.3% |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| msi-stable | 16 | |
| unknown | 6 | 27.3% |
Most occurring characters
| Value | Count | Frequency (%) |
| S | 32 | |
| n | 18 | |
| I | 16 | |
| - | 16 | |
| t | 16 | |
| M | 16 | |
| a | 16 | |
| b | 16 | |
| e | 16 | |
| l | 16 | |
| Other values (4) | 24 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 202 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| S | 32 | |
| n | 18 | |
| I | 16 | |
| - | 16 | |
| t | 16 | |
| M | 16 | |
| a | 16 | |
| b | 16 | |
| e | 16 | |
| l | 16 | |
| Other values (4) | 24 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 202 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| S | 32 | |
| n | 18 | |
| I | 16 | |
| - | 16 | |
| t | 16 | |
| M | 16 | |
| a | 16 | |
| b | 16 | |
| e | 16 | |
| l | 16 | |
| Other values (4) | 24 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 202 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| S | 32 | |
| n | 18 | |
| I | 16 | |
| - | 16 | |
| t | 16 | |
| M | 16 | |
| a | 16 | |
| b | 16 | |
| e | 16 | |
| l | 16 | |
| Other values (4) | 24 |
CollectionDate
Categorical
High correlation  Uniform 
| Distinct | 10 |
|---|---|
| Distinct (%) | 45.5% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| 01/2015 | |
|---|---|
| 07/2019 | |
| 08/2018 | |
| 11/2021 | |
| 04/2018 | |
| Other values (5) |
Length
| Max length | 7 |
|---|---|
| Median length | 7 |
| Mean length | 7 |
| Min length | 7 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | 11/2021 |
|---|---|
| 2nd row | 11/2021 |
| 3rd row | 08/2018 |
| 4th row | 08/2018 |
| 5th row | 04/2018 |
Common Values
| Value | Count | Frequency (%) |
| 01/2015 | 3 | |
| 07/2019 | 3 | |
| 08/2018 | 2 | |
| 11/2021 | 2 | |
| 04/2018 | 2 | |
| 07/2016 | 2 | |
| 03/2016 | 2 | |
| 04/2017 | 2 | |
| 07/2017 | 2 | |
| 01/2016 | 2 |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| 01/2015 | 3 | |
| 07/2019 | 3 | |
| 08/2018 | 2 | |
| 11/2021 | 2 | |
| 04/2018 | 2 | |
| 07/2016 | 2 | |
| 03/2016 | 2 | |
| 04/2017 | 2 | |
| 07/2017 | 2 | |
| 01/2016 | 2 |
Most occurring characters
| Value | Count | Frequency (%) |
| 0 | 42 | |
| 1 | 31 | |
| 2 | 24 | |
| / | 22 | |
| 7 | 11 | 7.1% |
| 6 | 6 | 3.9% |
| 8 | 6 | 3.9% |
| 4 | 4 | 2.6% |
| 5 | 3 | 1.9% |
| 9 | 3 | 1.9% |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 154 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 0 | 42 | |
| 1 | 31 | |
| 2 | 24 | |
| / | 22 | |
| 7 | 11 | 7.1% |
| 6 | 6 | 3.9% |
| 8 | 6 | 3.9% |
| 4 | 4 | 2.6% |
| 5 | 3 | 1.9% |
| 9 | 3 | 1.9% |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 154 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 0 | 42 | |
| 1 | 31 | |
| 2 | 24 | |
| / | 22 | |
| 7 | 11 | 7.1% |
| 6 | 6 | 3.9% |
| 8 | 6 | 3.9% |
| 4 | 4 | 2.6% |
| 5 | 3 | 1.9% |
| 9 | 3 | 1.9% |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 154 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 0 | 42 | |
| 1 | 31 | |
| 2 | 24 | |
| / | 22 | |
| 7 | 11 | 7.1% |
| 6 | 6 | 3.9% |
| 8 | 6 | 3.9% |
| 4 | 4 | 2.6% |
| 5 | 3 | 1.9% |
| 9 | 3 | 1.9% |
Human PathogenTesting Summary
Categorical
High correlation 
| Distinct | 4 |
|---|---|
| Distinct (%) | 18.2% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| Negative | |
|---|---|
| Negative | |
| Negative | |
| Negative |
Length
| Max length | 10 |
|---|---|
| Median length | 8 |
| Mean length | 8.4545455 |
| Min length | 8 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | Negative |
|---|---|
| 2nd row | Negative |
| 3rd row | Negative |
| 4th row | Negative |
| 5th row | Negative |
Common Values
| Value | Count | Frequency (%) |
| Negative | 15 | |
| Negative | 3 | 13.6% |
| Negative | 2 | 9.1% |
| Negative | 2 | 9.1% |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| negative | 22 |
Most occurring characters
| Value | Count | Frequency (%) |
| e | 44 | |
| N | 22 | |
| g | 22 | |
| a | 22 | |
| t | 22 | |
| i | 22 | |
| v | 22 | |
| 5 | 2.7% | |
| 5 | 2.7% |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 186 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| e | 44 | |
| N | 22 | |
| g | 22 | |
| a | 22 | |
| t | 22 | |
| i | 22 | |
| v | 22 | |
| 5 | 2.7% | |
| 5 | 2.7% |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 186 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| e | 44 | |
| N | 22 | |
| g | 22 | |
| a | 22 | |
| t | 22 | |
| i | 22 | |
| v | 22 | |
| 5 | 2.7% | |
| 5 | 2.7% |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 186 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| e | 44 | |
| N | 22 | |
| g | 22 | |
| a | 22 | |
| t | 22 | |
| i | 22 | |
| v | 22 | |
| 5 | 2.7% | |
| 5 | 2.7% |
Able to ViablyPassage in nude mice
Categorical
High correlation 
| Distinct | 3 |
|---|---|
| Distinct (%) | 13.6% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| Unknown | |
|---|---|
| Yes | |
| No |
Length
| Max length | 7 |
|---|---|
| Median length | 5 |
| Mean length | 4.8636364 |
| Min length | 2 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | Yes |
|---|---|
| 2nd row | Yes |
| 3rd row | Unknown |
| 4th row | Unknown |
| 5th row | Unknown |
Common Values
| Value | Count | Frequency (%) |
| Unknown | 11 | |
| Yes | 8 | |
| No | 3 | 13.6% |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| unknown | 11 | |
| yes | 8 | |
| no | 3 | 13.6% |
Most occurring characters
| Value | Count | Frequency (%) |
| n | 33 | |
| o | 14 | |
| U | 11 | 10.3% |
| k | 11 | 10.3% |
| w | 11 | 10.3% |
| Y | 8 | 7.5% |
| e | 8 | 7.5% |
| s | 8 | 7.5% |
| N | 3 | 2.8% |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 107 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| n | 33 | |
| o | 14 | |
| U | 11 | 10.3% |
| k | 11 | 10.3% |
| w | 11 | 10.3% |
| Y | 8 | 7.5% |
| e | 8 | 7.5% |
| s | 8 | 7.5% |
| N | 3 | 2.8% |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 107 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| n | 33 | |
| o | 14 | |
| U | 11 | 10.3% |
| k | 11 | 10.3% |
| w | 11 | 10.3% |
| Y | 8 | 7.5% |
| e | 8 | 7.5% |
| s | 8 | 7.5% |
| N | 3 | 2.8% |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 107 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| n | 33 | |
| o | 14 | |
| U | 11 | 10.3% |
| k | 11 | 10.3% |
| w | 11 | 10.3% |
| Y | 8 | 7.5% |
| e | 8 | 7.5% |
| s | 8 | 7.5% |
| N | 3 | 2.8% |
Age atSampling
Real number (ℝ)
High correlation 
| Distinct | 9 |
|---|---|
| Distinct (%) | 40.9% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Infinite | 0 |
| Infinite (%) | 0.0% |
| Mean | 53.045455 |
| Minimum | 32 |
|---|---|
| Maximum | 81 |
| Zeros | 0 |
| Zeros (%) | 0.0% |
| Negative | 0 |
| Negative (%) | 0.0% |
| Memory size | 308.0 B |
Quantile statistics
| Minimum | 32 |
|---|---|
| 5-th percentile | 32 |
| Q1 | 39 |
| median | 55.5 |
| Q3 | 67 |
| 95-th percentile | 80.4 |
| Maximum | 81 |
| Range | 49 |
| Interquartile range (IQR) | 28 |
Descriptive statistics
| Standard deviation | 16.220144 |
|---|---|
| Coefficient of variation (CV) | 0.30577821 |
| Kurtosis | -1.2968361 |
| Mean | 53.045455 |
| Median Absolute Deviation (MAD) | 15 |
| Skewness | 0.14859199 |
| Sum | 1167 |
| Variance | 263.09307 |
| Monotonicity | Not monotonic |
| Value | Count | Frequency (%) |
| 39 | 4 | |
| 67 | 3 | |
| 32 | 3 | |
| 59 | 2 | |
| 36 | 2 | |
| 60 | 2 | |
| 52 | 2 | |
| 69 | 2 | |
| 81 | 2 |
| Value | Count | Frequency (%) |
| 32 | 3 | |
| 36 | 2 | |
| 39 | 4 | |
| 52 | 2 | |
| 59 | 2 | |
| 60 | 2 | |
| 67 | 3 | |
| 69 | 2 | |
| 81 | 2 |
| Value | Count | Frequency (%) |
| 81 | 2 | |
| 69 | 2 | |
| 67 | 3 | |
| 60 | 2 | |
| 59 | 2 | |
| 52 | 2 | |
| 39 | 4 | |
| 36 | 2 | |
| 32 | 3 |
ModelNotes
Categorical
High correlation  Missing 
| Distinct | 3 |
|---|---|
| Distinct (%) | 27.3% |
| Missing | 11 |
| Missing (%) | 50.0% |
| Memory size | 308.0 B |
| No PDX Growth | |
|---|---|
| PDX Model Derivation: P0 slow growth; material pooled from Day 300 tumor due to age-related mortality and implanted into P1. | |
| PDX IHC/Path: CD34+ (diffusely), SMA+ (rare cells) |
Length
| Max length | 124 |
|---|---|
| Median length | 14 |
| Mean length | 50.545455 |
| Min length | 14 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | PDX IHC/Path: CD34+ (diffusely), SMA+ (rare cells) |
|---|---|
| 2nd row | PDX IHC/Path: CD34+ (diffusely), SMA+ (rare cells) |
| 3rd row | No PDX Growth |
| 4th row | No PDX Growth |
| 5th row | No PDX Growth |
Common Values
| Value | Count | Frequency (%) |
| No PDX Growth | 6 | |
| PDX Model Derivation: P0 slow growth; material pooled from Day 300 tumor due to age-related mortality and implanted into P1. | 3 | 13.6% |
| PDX IHC/Path: CD34+ (diffusely), SMA+ (rare cells) | 2 | 9.1% |
| (Missing) | 11 |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| pdx | 11 | 12.0% |
| growth | 9 | 9.8% |
| no | 6 | 6.5% |
| model | 3 | 3.3% |
| derivation | 3 | 3.3% |
| p0 | 3 | 3.3% |
| slow | 3 | 3.3% |
| material | 3 | 3.3% |
| pooled | 3 | 3.3% |
| from | 3 | 3.3% |
| Other values (17) | 45 |
Most occurring characters
| Value | Count | Frequency (%) |
| 87 | ||
| o | 45 | 8.1% |
| t | 38 | 6.8% |
| e | 33 | 5.9% |
| r | 31 | 5.6% |
| a | 31 | 5.6% |
| l | 27 | 4.9% |
| i | 20 | 3.6% |
| d | 20 | 3.6% |
| P | 19 | 3.4% |
| Other values (35) | 205 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 556 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 87 | ||
| o | 45 | 8.1% |
| t | 38 | 6.8% |
| e | 33 | 5.9% |
| r | 31 | 5.6% |
| a | 31 | 5.6% |
| l | 27 | 4.9% |
| i | 20 | 3.6% |
| d | 20 | 3.6% |
| P | 19 | 3.4% |
| Other values (35) | 205 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 556 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 87 | ||
| o | 45 | 8.1% |
| t | 38 | 6.8% |
| e | 33 | 5.9% |
| r | 31 | 5.6% |
| a | 31 | 5.6% |
| l | 27 | 4.9% |
| i | 20 | 3.6% |
| d | 20 | 3.6% |
| P | 19 | 3.4% |
| Other values (35) | 205 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 556 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 87 | ||
| o | 45 | 8.1% |
| t | 38 | 6.8% |
| e | 33 | 5.9% |
| r | 31 | 5.6% |
| a | 31 | 5.6% |
| l | 27 | 4.9% |
| i | 20 | 3.6% |
| d | 20 | 3.6% |
| P | 19 | 3.4% |
| Other values (35) | 205 |
ProvidedTissue Origin
Categorical
High correlation  Imbalance 
| Distinct | 2 |
|---|---|
| Distinct (%) | 9.1% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 308.0 B |
| Primary | |
|---|---|
| Metastatic Site | 2 |
Length
| Max length | 15 |
|---|---|
| Median length | 7 |
| Mean length | 7.7272727 |
| Min length | 7 |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | Metastatic Site |
|---|---|
| 2nd row | Metastatic Site |
| 3rd row | Primary |
| 4th row | Primary |
| 5th row | Primary |
Common Values
| Value | Count | Frequency (%) |
| Primary | 20 | |
| Metastatic Site | 2 | 9.1% |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| primary | 20 | |
| metastatic | 2 | 8.3% |
| site | 2 | 8.3% |
Most occurring characters
| Value | Count | Frequency (%) |
| r | 40 | |
| a | 24 | |
| i | 24 | |
| P | 20 | |
| m | 20 | |
| y | 20 | |
| t | 8 | 4.7% |
| e | 4 | 2.4% |
| M | 2 | 1.2% |
| s | 2 | 1.2% |
| Other values (3) | 6 | 3.5% |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 170 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| r | 40 | |
| a | 24 | |
| i | 24 | |
| P | 20 | |
| m | 20 | |
| y | 20 | |
| t | 8 | 4.7% |
| e | 4 | 2.4% |
| M | 2 | 1.2% |
| s | 2 | 1.2% |
| Other values (3) | 6 | 3.5% |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 170 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| r | 40 | |
| a | 24 | |
| i | 24 | |
| P | 20 | |
| m | 20 | |
| y | 20 | |
| t | 8 | 4.7% |
| e | 4 | 2.4% |
| M | 2 | 1.2% |
| s | 2 | 1.2% |
| Other values (3) | 6 | 3.5% |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 170 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| r | 40 | |
| a | 24 | |
| i | 24 | |
| P | 20 | |
| m | 20 | |
| y | 20 | |
| t | 8 | 4.7% |
| e | 4 | 2.4% |
| M | 2 | 1.2% |
| s | 2 | 1.2% |
| Other values (3) | 6 | 3.5% |
Interactions
Correlations
| Able to ViablyPassage in nude mice | Age atDiagnosis | Age atSampling | BiologicalSex | BiopsySite | CollectionDate | Date ofDiagnosis | Grade StageInformation | Has KnownMetastaticDisease | Has Smoked100 Cigarettes | Human PathogenTesting Summary | MSI Status | ModelNotes | Molecular andIHC Data | Occupation | PDX GrowthCurve Avail | Patient ID | PatientNotes | ProvidedTissue Origin | Self-ReportedEthnicity | Self-ReportedRace | Specimen ID | StandardizedRegimen | Timing | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Able to ViablyPassage in nude mice | 1.000 | 0.647 | 0.749 | 0.369 | 0.752 | 0.795 | 0.795 | 0.537 | 0.551 | 0.236 | 0.339 | 0.542 | 1.000 | 0.866 | 0.791 | 0.542 | 0.795 | 0.816 | 0.289 | 0.256 | 0.536 | 0.795 | 0.211 | 0.000 |
| Age atDiagnosis | 0.647 | 1.000 | 0.960 | 0.581 | 0.825 | 0.866 | 0.866 | 0.707 | 0.374 | 0.664 | 0.560 | 0.520 | 0.500 | 0.926 | 0.877 | 0.520 | 0.090 | 0.943 | 0.327 | 0.560 | 0.494 | 0.866 | 0.384 | 0.000 |
| Age atSampling | 0.749 | 0.960 | 1.000 | 0.381 | 0.785 | 0.866 | 0.866 | 0.871 | 0.588 | 0.568 | 0.560 | 0.715 | 0.866 | 0.926 | 0.877 | 0.715 | 0.223 | 0.943 | 0.472 | 0.560 | 0.494 | 0.866 | 0.363 | 0.000 |
| BiologicalSex | 0.369 | 0.581 | 0.381 | 1.000 | 0.676 | 0.775 | 0.775 | 0.307 | 0.000 | 0.381 | 0.426 | 0.000 | 0.588 | 0.816 | 0.767 | 0.000 | 0.775 | 0.784 | 0.000 | 0.214 | 0.787 | 0.775 | 0.529 | 0.000 |
| BiopsySite | 0.752 | 0.825 | 0.785 | 0.676 | 1.000 | 0.961 | 0.961 | 0.763 | 0.666 | 0.827 | 0.708 | 0.640 | 0.866 | 1.000 | 0.953 | 0.640 | 0.961 | 0.943 | 0.806 | 0.806 | 0.827 | 0.961 | 0.287 | 0.000 |
| CollectionDate | 0.795 | 0.866 | 0.866 | 0.775 | 0.961 | 1.000 | 1.000 | 0.840 | 0.775 | 0.795 | 0.816 | 0.775 | 0.866 | 1.000 | 1.000 | 0.775 | 1.000 | 1.000 | 0.775 | 0.775 | 0.795 | 1.000 | 0.292 | 0.000 |
| Date ofDiagnosis | 0.795 | 0.866 | 0.866 | 0.775 | 0.961 | 1.000 | 1.000 | 0.840 | 0.775 | 0.795 | 0.816 | 0.775 | 0.866 | 1.000 | 1.000 | 0.775 | 1.000 | 1.000 | 0.775 | 0.775 | 0.795 | 1.000 | 0.292 | 0.000 |
| Grade StageInformation | 0.537 | 0.707 | 0.871 | 0.307 | 0.763 | 0.840 | 0.840 | 1.000 | 0.278 | 0.435 | 0.000 | 0.675 | 0.866 | 0.866 | 0.845 | 0.675 | 0.840 | 0.894 | 0.922 | 0.000 | 0.156 | 0.840 | 0.419 | 0.000 |
| Has KnownMetastaticDisease | 0.551 | 0.374 | 0.588 | 0.000 | 0.666 | 0.775 | 0.775 | 0.278 | 1.000 | 0.112 | 0.397 | 0.289 | 0.943 | 0.816 | 0.767 | 0.289 | 0.775 | 0.784 | 0.133 | 0.000 | 0.000 | 0.775 | 0.000 | 0.000 |
| Has Smoked100 Cigarettes | 0.236 | 0.664 | 0.568 | 0.381 | 0.827 | 0.795 | 0.795 | 0.435 | 0.112 | 1.000 | 0.720 | 0.274 | 0.554 | 0.816 | 0.767 | 0.274 | 0.795 | 0.784 | 0.071 | 0.975 | 0.669 | 0.795 | 0.231 | 0.000 |
| Human PathogenTesting Summary | 0.339 | 0.560 | 0.560 | 0.426 | 0.708 | 0.816 | 0.816 | 0.000 | 0.397 | 0.720 | 1.000 | 0.184 | 1.000 | 0.816 | 0.791 | 0.184 | 0.816 | 0.784 | 0.000 | 0.949 | 0.669 | 0.816 | 0.274 | 0.000 |
| MSI Status | 0.542 | 0.520 | 0.715 | 0.000 | 0.640 | 0.775 | 0.775 | 0.675 | 0.289 | 0.274 | 0.184 | 1.000 | 0.943 | 0.816 | 0.767 | 0.879 | 0.775 | 0.784 | 0.000 | 0.000 | 0.354 | 0.775 | 0.000 | 0.000 |
| ModelNotes | 1.000 | 0.500 | 0.866 | 0.588 | 0.866 | 0.866 | 0.866 | 0.866 | 0.943 | 0.554 | 1.000 | 0.943 | 1.000 | 1.000 | 0.866 | 0.943 | 0.866 | 0.866 | 0.943 | 1.000 | 0.943 | 0.866 | 0.408 | 0.000 |
| Molecular andIHC Data | 0.866 | 0.926 | 0.926 | 0.816 | 1.000 | 1.000 | 1.000 | 0.866 | 0.816 | 0.816 | 0.816 | 0.816 | 1.000 | 1.000 | 1.000 | 0.816 | 1.000 | 1.000 | 0.816 | 1.000 | 0.816 | 1.000 | 0.535 | 0.000 |
| Occupation | 0.791 | 0.877 | 0.877 | 0.767 | 0.953 | 1.000 | 1.000 | 0.845 | 0.767 | 0.767 | 0.791 | 0.767 | 0.866 | 1.000 | 1.000 | 0.767 | 1.000 | 1.000 | 0.767 | 1.000 | 0.767 | 1.000 | 0.375 | 0.000 |
| PDX GrowthCurve Avail | 0.542 | 0.520 | 0.715 | 0.000 | 0.640 | 0.775 | 0.775 | 0.675 | 0.289 | 0.274 | 0.184 | 0.879 | 0.943 | 0.816 | 0.767 | 1.000 | 0.775 | 0.784 | 0.000 | 0.000 | 0.354 | 0.775 | 0.000 | 0.000 |
| Patient ID | 0.795 | 0.090 | 0.223 | 0.775 | 0.961 | 1.000 | 1.000 | 0.840 | 0.775 | 0.795 | 0.816 | 0.775 | 0.866 | 1.000 | 1.000 | 0.775 | 1.000 | 1.000 | 0.775 | 0.775 | 0.795 | 1.000 | 0.292 | 0.000 |
| PatientNotes | 0.816 | 0.943 | 0.943 | 0.784 | 0.943 | 1.000 | 1.000 | 0.894 | 0.784 | 0.784 | 0.784 | 0.784 | 0.866 | 1.000 | 1.000 | 0.784 | 1.000 | 1.000 | 0.784 | 1.000 | 0.784 | 1.000 | 0.433 | 0.000 |
| ProvidedTissue Origin | 0.289 | 0.327 | 0.472 | 0.000 | 0.806 | 0.775 | 0.775 | 0.922 | 0.133 | 0.071 | 0.000 | 0.000 | 0.943 | 0.816 | 0.767 | 0.000 | 0.775 | 0.784 | 1.000 | 0.000 | 0.000 | 0.775 | 0.543 | 0.000 |
| Self-ReportedEthnicity | 0.256 | 0.560 | 0.560 | 0.214 | 0.806 | 0.775 | 0.775 | 0.000 | 0.000 | 0.975 | 0.949 | 0.000 | 1.000 | 1.000 | 1.000 | 0.000 | 0.775 | 1.000 | 0.000 | 1.000 | 0.975 | 0.775 | 0.348 | 0.000 |
| Self-ReportedRace | 0.536 | 0.494 | 0.494 | 0.787 | 0.827 | 0.795 | 0.795 | 0.156 | 0.000 | 0.669 | 0.669 | 0.354 | 0.943 | 0.816 | 0.767 | 0.354 | 0.795 | 0.784 | 0.000 | 0.975 | 1.000 | 0.795 | 0.320 | 0.000 |
| Specimen ID | 0.795 | 0.866 | 0.866 | 0.775 | 0.961 | 1.000 | 1.000 | 0.840 | 0.775 | 0.795 | 0.816 | 0.775 | 0.866 | 1.000 | 1.000 | 0.775 | 1.000 | 1.000 | 0.775 | 0.775 | 0.795 | 1.000 | 0.292 | 0.000 |
| StandardizedRegimen | 0.211 | 0.384 | 0.363 | 0.529 | 0.287 | 0.292 | 0.292 | 0.419 | 0.000 | 0.231 | 0.274 | 0.000 | 0.408 | 0.535 | 0.375 | 0.000 | 0.292 | 0.433 | 0.543 | 0.348 | 0.320 | 0.292 | 1.000 | 0.586 |
| Timing | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.586 | 1.000 |
Missing values
Sample
| Patient ID | Timing | Date RegimenStarted | StandardizedRegimen | Best Response | Self-ReportedRace | Self-ReportedEthnicity | BiologicalSex | Age atDiagnosis | AdditionalMedicalHistory | Date ofDiagnosis | Grade StageInformation | Has KnownMetastaticDisease | Has Smoked100 Cigarettes | Molecular andIHC Data | Occupation | PatientNotes | Specimen ID | BiopsySite | PDX GrowthCurve Avail | MSI Status | CollectionDate | Human PathogenTesting Summary | Able to ViablyPassage in nude mice | Age atSampling | ModelNotes | ProvidedTissue Origin | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 111316 | Current | 08/2021 | Ripretinib | NaN | White | Not Hispanic or Latino | Male | 58 | Final Pathology: Dx confirmed; mitotic rate is 47/30 HPF; treatment effect present w/central necrosis. | 07/2020 | Grade, TNM (Clinical) | Yes | No | IHC: DOG1+, CD117+; S100-, CK AE1/AE3- | Engineer | Tumor Grade/Stage: cM0 (at diagnosis); high grade \nLocation of known metastasis: liver, jejunum, ileum | 319-R | Liver [central] | Yes | MSI-Stable | 11/2021 | Negative | Yes | 59 | PDX IHC/Path: CD34+ (diffusely), SMA+ (rare cells) | Metastatic Site |
| 1 | 111316 | Prior | 07/2020 | Imatinib Mesylate | NaN | White | Not Hispanic or Latino | Male | 58 | Final Pathology: Dx confirmed; mitotic rate is 47/30 HPF; treatment effect present w/central necrosis. | 07/2020 | Grade, TNM (Clinical) | Yes | No | IHC: DOG1+, CD117+; S100-, CK AE1/AE3- | Engineer | Tumor Grade/Stage: cM0 (at diagnosis); high grade \nLocation of known metastasis: liver, jejunum, ileum | 319-R | Liver [central] | Yes | MSI-Stable | 11/2021 | Negative | Yes | 59 | PDX IHC/Path: CD34+ (diffusely), SMA+ (rare cells) | Metastatic Site |
| 2 | 246632 | Prior | NaN | Treatment naive | NaN | White | Not Hispanic or Latino | Male | 35 | Concurrent malignancy - SDHB gene mutation associated paraganglioma | 11/2017 | None Provided | Not Reported | No | c.445C>T (p.Q149*) variant in the SDHB gene | insurance industry | Pt has concurrent malignancies - GIST and SDHB gene mutation associated paraganglioma | 235-R1 | Gastric | No | Unknown | 08/2018 | Negative | Unknown | 36 | No PDX Growth | Primary |
| 3 | 246632 | Current | NaN | Treatment naive | NaN | White | Not Hispanic or Latino | Male | 35 | Concurrent malignancy - SDHB gene mutation associated paraganglioma | 11/2017 | None Provided | Not Reported | No | c.445C>T (p.Q149*) variant in the SDHB gene | insurance industry | Pt has concurrent malignancies - GIST and SDHB gene mutation associated paraganglioma | 235-R1 | Gastric | No | Unknown | 08/2018 | Negative | Unknown | 36 | No PDX Growth | Primary |
| 4 | 358529 | Prior | 01/2018 | Imatinib Mesylate | PR | White | Not Hispanic or Latino | Female | 51 | Final Pathology: Dx confirmed with treatment effect present; 50% viable tumor remains | 12/2017 | Grade, TNM (Pathological) | Not Reported | Yes | NaN | Department Manger | Tumor Stage/Grade: G1 - 1 low grade; pT3 pN0 pM not applicable | 109-R | Stomach | No | Unknown | 04/2018 | Negative | Unknown | 52 | No PDX Growth | Primary |
| 5 | 358529 | Current | NaN | No Current Therapy | NaN | White | Not Hispanic or Latino | Female | 51 | Final Pathology: Dx confirmed with treatment effect present; 50% viable tumor remains | 12/2017 | Grade, TNM (Pathological) | Not Reported | Yes | NaN | Department Manger | Tumor Stage/Grade: G1 - 1 low grade; pT3 pN0 pM not applicable | 109-R | Stomach | No | Unknown | 04/2018 | Negative | Unknown | 52 | No PDX Growth | Primary |
| 6 | 429767 | Prior | 05/2007 | Imatinib Mesylate | Stable Disease | Black or African American | Not Hispanic or Latino | Female | 53 | Site of resection included spleen, kidney, distal pancreatectomy and retroperitoneal tumor | 01/2007 | None Provided | Yes | Yes | NaN | Disabled | NaN | 202-R | Abdominal Mass | Yes | MSI-Stable | 07/2016 | Negative | Yes | 60 | NaN | Primary |
| 7 | 429767 | Current | NaN | No Current Therapy | NaN | Black or African American | Not Hispanic or Latino | Female | 53 | Site of resection included spleen, kidney, distal pancreatectomy and retroperitoneal tumor | 01/2007 | None Provided | Yes | Yes | NaN | Disabled | NaN | 202-R | Abdominal Mass | Yes | MSI-Stable | 07/2016 | Negative | Yes | 60 | NaN | Primary |
| 8 | 627122 | Prior | NaN | Treatment naive | NaN | White | Not Hispanic or Latino | Male | 39 | NaN | 02/2017 | None Provided | Not Reported | No | NaN | Park Service | NaN | 101-R | Gastric Fundus | Yes | MSI-Stable | 04/2017 | Negative | Yes | 39 | NaN | Primary |
| 9 | 627122 | Current | NaN | Treatment naive | NaN | White | Not Hispanic or Latino | Male | 39 | NaN | 02/2017 | None Provided | Not Reported | No | NaN | Park Service | NaN | 101-R | Gastric Fundus | Yes | MSI-Stable | 04/2017 | Negative | Yes | 39 | NaN | Primary |
| Patient ID | Timing | Date RegimenStarted | StandardizedRegimen | Best Response | Self-ReportedRace | Self-ReportedEthnicity | BiologicalSex | Age atDiagnosis | AdditionalMedicalHistory | Date ofDiagnosis | Grade StageInformation | Has KnownMetastaticDisease | Has Smoked100 Cigarettes | Molecular andIHC Data | Occupation | PatientNotes | Specimen ID | BiopsySite | PDX GrowthCurve Avail | MSI Status | CollectionDate | Human PathogenTesting Summary | Able to ViablyPassage in nude mice | Age atSampling | ModelNotes | ProvidedTissue Origin | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12 | 738633 | Prior | 03/2014 | Imatinib Mesylate | NaN | Not Provided | Not Provided | Female | 31 | NaN | 03/2014 | None Provided | Not Reported | Not Provided | NaN | NaN | NaN | 008-R | Stomach/Liver | Yes | MSI-Stable | 01/2015 | Negative \n | Unknown | 32 | NaN | Primary |
| 13 | 738633 | Current | NaN | No Current Therapy | <Unknown> | Not Provided | Not Provided | Female | 31 | NaN | 03/2014 | None Provided | Not Reported | Not Provided | NaN | NaN | NaN | 008-R | Stomach/Liver | Yes | MSI-Stable | 01/2015 | Negative \n | Unknown | 32 | NaN | Primary |
| 14 | 738633 | Prior | 07/2014 | Sunitinib Malate | Non-evaluable | Not Provided | Not Provided | Female | 31 | NaN | 03/2014 | None Provided | Not Reported | Not Provided | NaN | NaN | NaN | 008-R | Stomach/Liver | Yes | MSI-Stable | 01/2015 | Negative \n | Unknown | 32 | NaN | Primary |
| 15 | 814656 | Prior | 07/2013 | Imatinib Mesylate | CR | Black or African American | Not Hispanic or Latino | Female | 57 | NaN | 07/2009 | Grade, TNM | Not Reported | No | Biomarkers: c-KIT mutated, DOG1+ | Not Provided | Disease recurrence at distant site\nTumor Grade/Stage: Grade 2, T2N0M1\n | 196-R | Stomach [distal] | Yes | MSI-Stable | 07/2019 | Negative | No | 67 | PDX Model Derivation: P0 slow growth; material pooled from Day 300 tumor due to age-related mortality and implanted into P1. | Primary |
| 16 | 814656 | Current | 01/2016 | Imatinib Mesylate | NaN | Black or African American | Not Hispanic or Latino | Female | 57 | NaN | 07/2009 | Grade, TNM | Not Reported | No | Biomarkers: c-KIT mutated, DOG1+ | Not Provided | Disease recurrence at distant site\nTumor Grade/Stage: Grade 2, T2N0M1\n | 196-R | Stomach [distal] | Yes | MSI-Stable | 07/2019 | Negative | No | 67 | PDX Model Derivation: P0 slow growth; material pooled from Day 300 tumor due to age-related mortality and implanted into P1. | Primary |
| 17 | 814656 | Prior | 07/2009 | Imatinib Mesylate | PR | Black or African American | Not Hispanic or Latino | Female | 57 | NaN | 07/2009 | Grade, TNM | Not Reported | No | Biomarkers: c-KIT mutated, DOG1+ | Not Provided | Disease recurrence at distant site\nTumor Grade/Stage: Grade 2, T2N0M1\n | 196-R | Stomach [distal] | Yes | MSI-Stable | 07/2019 | Negative | No | 67 | PDX Model Derivation: P0 slow growth; material pooled from Day 300 tumor due to age-related mortality and implanted into P1. | Primary |
| 18 | 899375 | Current | NaN | No Current Therapy | NaN | White | Not Hispanic or Latino | Male | 80 | Prior Malignancy: Prostate Cancer | 06/2017 | TNM (Pathological) | Not Reported | Yes | NaN | Retired; prior occupation not provided | Tumor Grade/Stage: pT2NX\n | 194-R | Stomach | No | Unknown | 07/2017 | Negative | Unknown | 81 | No PDX Growth | Primary |
| 19 | 899375 | Prior | 01/2012 | Radiation | NaN | White | Not Hispanic or Latino | Male | 80 | Prior Malignancy: Prostate Cancer | 06/2017 | TNM (Pathological) | Not Reported | Yes | NaN | Retired; prior occupation not provided | Tumor Grade/Stage: pT2NX\n | 194-R | Stomach | No | Unknown | 07/2017 | Negative | Unknown | 81 | No PDX Growth | Primary |
| 20 | 949853 | Current | NaN | Treatment naive | NaN | White | Not Hispanic or Latino | Male | 39 | Final Pathology: Stomach - Dx confirmed, predominantly spindle-cell type. Mitotic count: 80 per 5mm2. Liver: Metastatic gastrointestinal stromal sarcoma. | 10/2015 | None Provided | Yes | Yes | IHC: DOG1+, CD117+, and PDGFR+ consistent with a gastrointestinal stromal tumor (GIST). | Plastics factory worker | Location of know metastases: liver | 013-R | Stomach | Yes | MSI-Stable | 01/2016 | Negative\n | Yes | 39 | NaN | Primary |
| 21 | 949853 | Prior | NaN | Treatment naive | NaN | White | Not Hispanic or Latino | Male | 39 | Final Pathology: Stomach - Dx confirmed, predominantly spindle-cell type. Mitotic count: 80 per 5mm2. Liver: Metastatic gastrointestinal stromal sarcoma. | 10/2015 | None Provided | Yes | Yes | IHC: DOG1+, CD117+, and PDGFR+ consistent with a gastrointestinal stromal tumor (GIST). | Plastics factory worker | Location of know metastases: liver | 013-R | Stomach | Yes | MSI-Stable | 01/2016 | Negative\n | Yes | 39 | NaN | Primary |